Dr. Prema Prabhudev*, Dr. Sapna I. S. and Dr. Saroja


Background: Hypertensive disorders of pregnancy accounts for the majority of referrals in a tertiary centre as it stands one of the major causes of maternal and perinatal morbidity and mortality. The objective was to study the maternal and foetal outcome in patient with hypertensive disorder in a tertiary centre over a period of one year. Hypertensive disorders of pregnancy still holds major cause of maternal and perinatal morbidity and mortality & the commonest cause of referral to a tertiary centre. The objective was to study the maternal and foetal outcome in patient with hypertensive disorder in a tertiary centre from june2016 to may2017 (one year). Method: Total number of women with severe preeclampsia and eclampsia after 20wks were 146. Women with medical complications were excluded. Hypertensive women were managed as per existing protocol of the institution, after detailed history, examination and investigations. Anti-hypertensive of choice was labetalol and oral nefedipine, Mgso4 was used as anti-convulsant. Result: Out of 146 cases of severe pre-eclampsia and eclampsia, majority 91(62.32%) were between 21-25yrs years of age and 76(52%) were primigravida. We had 21(14.38%) patients with h/o convulsions and 103(70.5%) with severe pre-eclampsia of whom 3(2.9%) had convulsions. Headache was most common complaint. Common mode of delivery was caesarean section 106(72.6%) women, majority in view of failed induction or non-progress. Maternal complications were noted 43(29.5%) attributed to renal dysfunction, postpartum haemorrhage, DIC, placental abruption, HELLP, pulmonary oedema Total 146 cases ,live birth 119 (81%), 24% were required NICU care 15(10.27%) cases were IUFD,4(2.73%) babies stillborn.2 (1.36%) neonatal deaths,1(0.68%) perinatal death. Conculusion: Maternal and perinatal complications are more in patients with eclampsia. The incidence of eclampsia can be reduced by regular antenatal care, early recognition and prompt treatment of severe pre-eclampsia.

Keywords: .

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    JANUARY 2019 Issue has been successfully launched on 1 January 2019

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 4.382 to 4.918 due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction